Woman With Vaccine Injury in Clinical Trial Sues AstraZeneca

Rise Up 'Deplorables': Rallying Round Pro-America Businesses
The Epoch Times Header

Brianne Dressen was diagnosed with a vaccine injury by U.S. government researchers.

An American woman who suffered an injury from AstraZeneca’s COVID-19 vaccine sued the company on May 13, alleging the company breached a contract by not paying for the medical care she requires to deal with the injury.

“They left us no choice,” Brianne Dressen, a preschool teacher in Utah, told The Epoch Times in an email.

Ms. Dressen has paid tens of thousands of dollars to drugs to treat the nervous system disorder and other issues she’s experiencing, according to the complaint, filed in federal court in her home state.

Ms. Dressen chose to participate in AstraZeneca’s clinical trial in 2020 because she wanted to help the company develop its COVID-19 vaccine. The consent form she signed stated in part that AstraZeneca would “cover the costs of research injuries” and “pay the costs of medical treatment.”

“With these reassurances should something go wrong, Bri signed the form, rolled up her sleeve, and let the drug company inject the experimental product into her arm. Her mind was at peace, as Bri believed she was doing the right thing for her country, her students, and her family,” the suit states.

Ms. Dressen soon started experiencing problems, including blurred vision, tinnitus, and vomiting. She later became extremely sensitive to light and suffered spikes in her heart rate.

Ms. Dressen went to see numerous doctors as she attempted to figure out what was wrong with her, and seek treatment.

In 2021, U.S. National Institutes of Health doctors diagnosed Ms. Dressen as having “post-vaccine neuropathy,” according to records reviewed by The Epoch Times.

Bills for the doctors’ visits and drugs they prescribed began piling up quickly. The immunoglobulin recommended by government doctors alone costs $9,909.82 a month.

Ms. Dressen and her husband, a chemist with the U.S. Army, kept AstraZeneca and Velocity, which ran the trial for the company, apprised of the accumulating costs, according to the suit.

The family messaged Velocity on Jan. 15, 2021, with the first set of payment records for treatment but received no response, according to the suit. “Checking on updates for this. . . . When may we expect payment?” Brian Dressen, Ms. Dressen’s husband, wrote several weeks later.

By Zachary Stieber

Read Full Article on TheEpochTimes.com

Contact Your Elected Officials